MEN2501

AssetAlso ISM9682

Inhibitor of the kinesin KIF18A motor protein, for cancers with chromosome instability

Stage: Phase 1
Modality: Small molecule
Target: KIF18A; 1
Indication: 1
Trial: 1
Developer

Indications

1

Platinum-resistant ovarian cancer
Phase 1, Recruiting, NCT07226427, clinicaltrials.gov, 8 Oct 2026

In the full profile

Targets and what it contains1
Owner and partners2
Trials1
Evidence for its targets1
Competitors2
Signals1

Every asset’s record: target, stage, trials and the evidence behind it.